Heinz Wiendl
Cited by
Cited by
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ...
Multiple Sclerosis Journal 24 (2), 96-120, 2018
Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis
S Wintterle, B Schreiner, M Mitsdoerffer, D Schneider, L Chen, ...
Cancer research 63 (21), 7462-7467, 2003
Acute disseminated encephalomyelitis: an update
T Menge, B Hemmer, S Nessler, H Wiendl, O Neuhaus, HP Hartung, ...
Archives of neurology 62 (11), 1673-1680, 2005
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro
C Blank, J Kuball, S Voelkl, H Wiendl, B Becker, B Walter, O Majdic, ...
International journal of cancer 119 (2), 317-327, 2006
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape
H Wiendl, M Mitsdoerffer, V Hofmeister, J Wischhusen, A Bornemann, ...
The Journal of Immunology 168 (9), 4772-4780, 2002
Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis
CG Bien, J Bauer, TL Deckwerth, H Wiendl, M Deckert, OD Wiestler, ...
Annals of Neurology: Official Journal of the American Neurological …, 2002
Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells
O Neuhaus, C Farina, A Yassouridis, H Wiendl, F Then Bergh, T Dose, ...
Proceedings of the National Academy of Sciences 97 (13), 7452-7457, 2000
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation
C Kleinschnitz, N Schwab, P Kraft, I Hagedorn, A Dreykluft, T Schwarz, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3835-3842, 2010
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in …
B Schreiner, M Mitsdoerffer, BC Kieseier, L Chen, HP Hartung, M Weller, ...
Journal of neuroimmunology 155 (1-2), 172-182, 2004
Clinical relevance of brain volume measures in multiple sclerosis
N De Stefano, L Airas, N Grigoriadis, HP Mattle, J O’Riordan, ...
CNS drugs 28 (2), 147-156, 2014
Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature
C Kleinschnitz, P Kraft, A Dreykluft, I Hagedorn, K Göbel, MK Schuhmann, ...
Blood, The Journal of the American Society of Hematology 121 (4), 679-691, 2013
Teriflunomide and its mechanism of action in multiple sclerosis
A Bar-Or, A Pachner, F Menguy-Vacheron, J Kaplan, H Wiendl
Drugs 74 (6), 659-674, 2014
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations
H Wiendl, KV Toyka, P Rieckmann, R Gold, HP Hartung, R Hohlfeld
Journal of neurology 255 (10), 1449-1463, 2008
Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis
L Kappos, H Wiendl, K Selmaj, DL Arnold, E Havrdova, A Boyko, ...
New England Journal of Medicine 373 (15), 1418-1428, 2015
The role of regulatory T cells in multiple sclerosis
AL Zozulya, H Wiendl
Nature clinical practice Neurology 4 (7), 384-398, 2008
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
A Kroner, M Mehling, B Hemmer, P Rieckmann, KV Toyka, M Mäurer, ...
Annals of neurology 58 (1), 50-57, 2005
HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation
U Feger, E Tolosa, YH Huang, A Waschbisch, T Biedermann, A Melms, ...
Blood, The Journal of the American Society of Hematology 110 (2), 568-577, 2007
Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients
U Feger, C Luther, S Poeschel, A Melms, E Tolosa, H Wiendl
Clinical & Experimental Immunology 147 (3), 412-418, 2007
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
HP Tony, G Burmester, H Schulze-Koops, M Grunke, J Henes, I Kötter, ...
Arthritis research & therapy 13 (3), 1-14, 2011
The system can't perform the operation now. Try again later.
Articles 1–20